Ifp Advisors, Inc Exelixis, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 2,053 shares of EXEL stock, worth $68,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,053

Previous 78 2532.05%

Holding current value

$68,056

Previous $1,000 4500.0%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$20.34 - $23.73 $40,171 - $46,866	1,975 Added 2532.05%	2,053 $46,000
Q1 2024 Jul 30, 2024	BUY	$20.17 - $23.93 $504 - $598	25 Added 47.17%	78 $1,000
Q2 2023 Aug 04, 2023	SELL	$18.17 - $20.48 $182,190 - $205,352	-10,027 Reduced 99.47%	53 $1,000
Q1 2023 Apr 18, 2023	SELL	$16.3 - $19.41 $14,474 - $17,236	-888 Reduced 8.1%	10,080 $195,000
Q4 2022 Feb 07, 2023	SELL	$14.96 - $17.39 $5,639 - $6,556	-377 Reduced 3.32%	10,968 $228,000
Q3 2022 Nov 08, 2022	BUY	$15.68 - $22.27 $9,408 - $13,362	600 Added 5.58%	11,345 $237,000
Q2 2022 Sep 06, 2022	BUY	$17.44 - $23.16 $187,392 - $248,854	10,745 New	10,745 $223,000
Q2 2022 Aug 12, 2022	SELL	$17.44 - $23.16 $187,392 - $248,854	-10,745 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$17.03 - $22.67 $27,026 - $35,977	1,587 Added 17.33%	10,745 $243,000
Q1 2022 Aug 08, 2022	BUY	$17.03 - $22.67 $1,413 - $1,881	83 Added 0.91%	9,158 $207,000
Q4 2021 Jan 12, 2022	BUY	$15.84 - $21.88 $26,516 - $36,627	1,674 Added 22.62%	9,075 $166,000
Q3 2021 Oct 06, 2021	SELL	$16.3 - $21.14 $3,553 - $4,608	-218 Reduced 2.86%	7,401 $157,000
Q2 2021 Jul 13, 2021	SELL	$17.95 - $25.56 $89 - $127	-5 Reduced 0.07%	7,619 $139,000
Q1 2021 Apr 30, 2021	BUY	$20.53 - $25.22 $21,782 - $26,758	1,061 Added 16.17%	7,624 $173,000
Q4 2020 Jan 25, 2021	BUY	$18.39 - $24.8 $5,572 - $7,514	303 Added 4.84%	6,563 $132,000
Q3 2020 Oct 29, 2020	SELL	$20.67 - $26.94 $2,046 - $2,667	-99 Reduced 1.56%	6,260 $151,000
Q2 2020 Aug 05, 2020	SELL	$16.46 - $27.42 $691 - $1,151	-42 Reduced 0.66%	6,359 $146,000
Q1 2020 May 12, 2020	BUY	$14.46 - $21.8 $2,082 - $3,139	144 Added 2.3%	6,401 $110,000
Q4 2019 Jan 17, 2020	SELL	$15.15 - $18.89 $4,651 - $5,799	-307 Reduced 4.68%	6,257 $112,000
Q3 2019 Nov 07, 2019	SELL	$17.68 - $22.65 $14,373 - $18,414	-813 Reduced 11.02%	6,564 $118,000
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $61,544 - $77,746	3,140 Added 74.11%	7,377 $177,000
Q4 2018 Jan 23, 2019	BUY	$13.65 - $21.8 $37,769 - $60,320	2,767 Added 188.23%	4,237 $83,000
Q3 2018 Oct 25, 2018	BUY	$15.87 - $22.4 $2,777 - $3,919	175 Added 13.51%	1,470 $0
Q2 2018 Aug 07, 2018	SELL	$18.56 - $22.45 $38,010 - $45,977	-2,048 Reduced 61.26%	1,295 $0
Q1 2018 Jun 03, 2019	BUY	$22.15 - $31.89 $17,631 - $25,384	796 Added 31.25%	3,343 $101,000
Q1 2018 May 09, 2018	BUY	$22.15 - $31.89 $4,518 - $6,505	204 Added 8.71%	2,547 $0
Q4 2017 Jan 24, 2018	SELL	$24.23 - $30.93 $3,634 - $4,639	-150 Reduced 6.02%	2,343 $0
Q3 2017 Oct 30, 2017	BUY	$23.35 - $29.24 $34,861 - $43,655	1,493 Added 149.3%	2,493 $60,000
Q2 2017 Jun 03, 2019	SELL	N/A	-550 Reduced 35.48%	1,000 $25,000
Q1 2017 Jun 03, 2019	SELL	N/A	-150 Reduced 8.82%	1,550 $34,000
Q4 2016 Jun 03, 2019	BUY	N/A	650 Added 61.9%	1,700 $25,000
Q2 2016 Jun 03, 2019	SELL	N/A	-6,327 Reduced 85.77%	1,050 $8,000
Q1 2016 Jun 03, 2019	BUY	N/A	7,377	7,377 $177,000

Others Institutions Holding EXEL

# of Institutions

520

Shares Held

244M

Call Options Held

2.84M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account